Found: 109
Select item for more details and to access through your institution.
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3429, doi. 10.1007/s00277-024-05851-4
- By:
- Publication type:
- Article
A Review of the Therapeutic Role of Bosutinib in Chronic Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 5, p. 285, doi. 10.1016/j.clml.2024.01.005
- By:
- Publication type:
- Article
Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia—Single-Centre Experience.
- Published in:
- Current Oncology, 2024, v. 31, n. 3, p. 1246, doi. 10.3390/curroncol31030093
- By:
- Publication type:
- Article
Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 2, p. 91, doi. 10.1007/s40261-023-01329-9
- By:
- Publication type:
- Article
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 2, p. 301, doi. 10.1111/ejh.14117
- By:
- Publication type:
- Article
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD) study.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 781, doi. 10.1111/bjh.19058
- By:
- Publication type:
- Article
Prognostic implication of pre-transplant FEV<sub>1</sub> on long-term outcomes following allogeneic hematopoietic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 5, p. 687, doi. 10.1111/ejh.14062
- By:
- Publication type:
- Article
Influence of conditioning regimen intensity on outcomes post‐allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 553, doi. 10.1111/ejh.14041
- By:
- Publication type:
- Article
Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 10, p. 1, doi. 10.1007/s00520-023-08022-9
- By:
- Publication type:
- Article
The expanding CML treatment landscape: an introspective commentary.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00918-3
- By:
- Publication type:
- Article
Treatment‐free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5‐year analysis of DASFREE.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 5, p. 942, doi. 10.1111/bjh.18883
- By:
- Publication type:
- Article
A Primed Neutrophil Subset Predicts the Risk of Bloodstream Infections in Allogeneic Hematopoietic Stem-Cell Transplant Patients: A Prospective Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 5, p. 752, doi. 10.1093/cid/ciad277
- By:
- Publication type:
- Article
A Pragmatic Approach to Managing Long-Term Adverse Effects in Chronic Myeloid Leukemia Treatment.
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 4, p. 98, doi. 10.1007/s11899-023-00698-4
- By:
- Publication type:
- Article
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 6, p. 1005, doi. 10.1515/cclm-2022-0916
- By:
- Publication type:
- Article
Management of chronic myeloid leukemia in 2023 – common ground and common sense.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00823-9
- By:
- Publication type:
- Article
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 917, doi. 10.1007/s00277-023-05135-3
- By:
- Publication type:
- Article
Management of chronic myeloid leukemia in 2023 – common ground and common sense.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00823-9
- By:
- Publication type:
- Article
Evaluation of a group-based exercise and relaxation rehabilitation program during hospitalization for allogeneic hematopoietic stem cell transplant.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2023, v. 15, n. 1, p. 51, doi. 10.1002/pmrj.12784
- By:
- Publication type:
- Article
A Qualitative Study of the Everyday Impacts of Cognitive Difficulties After Stem Cell Transplantation.
- Published in:
- Oncology Nursing Forum, 2022, v. 49, n. 4, p. 315, doi. 10.1188/22.ONF.315-325
- By:
- Publication type:
- Article
COVID-19 Vaccine Responses in Patients With Plasma Cell Dyscrasias After Complete Vaccination.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e321, doi. 10.1016/j.clml.2021.11.001
- By:
- Publication type:
- Article
Poor outcome after hematopoietic stem cell transplantation of patients with unclassified inherited bone marrow failure syndromes.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 4, p. 278, doi. 10.1111/ejh.13733
- By:
- Publication type:
- Article
Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 4, p. 288, doi. 10.1111/ejh.13735
- By:
- Publication type:
- Article
BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 136, doi. 10.1111/bjh.17807
- By:
- Publication type:
- Article
Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 61, doi. 10.1111/ejh.13714
- By:
- Publication type:
- Article
Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5543, doi. 10.3390/cancers13215543
- By:
- Publication type:
- Article
Oral Abstract: CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01274-X
- By:
- Publication type:
- Article
Poster: CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S223, doi. 10.1016/S2152-2650(21)01408-7
- By:
- Publication type:
- Article
CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S328, doi. 10.1016/S2152-2650(21)01769-9
- By:
- Publication type:
- Article
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 354, doi. 10.1111/ejh.13673
- By:
- Publication type:
- Article
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 779, doi. 10.1111/bjh.17447
- By:
- Publication type:
- Article
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Late cognitive outcomes among allogeneic stem cell transplant survivors: follow-up data from a 6-year longitudinal study.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 5, p. 2621, doi. 10.1007/s00520-020-05761-x
- By:
- Publication type:
- Article
Refined hepatic grading system in chronic graft‐versus‐host disease improves prognostic risk stratification of long‐term outcomes.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 508, doi. 10.1111/ejh.13576
- By:
- Publication type:
- Article
Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 3, p. 789, doi. 10.1007/s00277-020-04363-1
- By:
- Publication type:
- Article
Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely option.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. 179, doi. 10.1002/ajh.26033
- By:
- Publication type:
- Article
Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantation.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 2, p. 241, doi. 10.1111/ejh.13542
- By:
- Publication type:
- Article
Chronic myeloid leukemia in solid organ transplant patients: a case series.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 2, p. 214, doi. 10.1007/s12185-020-03014-5
- By:
- Publication type:
- Article
Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 1, p. 66, doi. 10.1159/000507536
- By:
- Publication type:
- Article
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 32, doi. 10.1111/ejh.13482
- By:
- Publication type:
- Article
Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 1, p. 33, doi. 10.1177/1078155220908948
- By:
- Publication type:
- Article
Avoiding the Thorns of the Gifted Red Rose: Case Report of Late Diagnosis of Polycythemia Rubra Vera in a Sibling Bone Marrow Transplantation Donor for a Patient with Chronic Myeloid Leukemia.
- Published in:
- 2020
- By:
- Publication type:
- Letter
CNS demyelination after initiating the tyrosine kinase inhibitor imatinib: A report of two cases.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 9, p. 1121, doi. 10.1177/1352458519892914
- By:
- Publication type:
- Article
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 976, doi. 10.1111/bjh.16445
- By:
- Publication type:
- Article
Exercise before, during, and after Hospitalization for Allogeneic Hematological Stem Cell Transplant: A Feasibility Randomized Controlled Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1854, doi. 10.3390/jcm9061854
- By:
- Publication type:
- Article
Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 1, p. 20, doi. 10.1007/s11899-020-00560-x
- By:
- Publication type:
- Article
Reanalysing genomic data by normalized coverage values uncovers CNVs in bone marrow failure gene panels.
- Published in:
- NPJ Genomic Medicine, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41525-019-0104-9
- By:
- Publication type:
- Article
ENESTop 192-Weeks Results: Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S288, doi. 10.1016/j.clml.2019.07.233
- By:
- Publication type:
- Article
DASFREE: Treatment-Free Remission (TFR) After Discontinuation of Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S299, doi. 10.1016/j.clml.2019.07.253
- By:
- Publication type:
- Article